**Core Concept**
The patient is presenting with signs of insulin resistance, likely due to truncal obesity, which is often associated with central fat distribution. The agent used in the treatment of this patient is likely to be a thiazolidinedione, a class of medications that improve insulin sensitivity.

**Why the Correct Answer is Right**
Thiazolidinediones, such as pioglitazone, work by activating the peroxisome proliferator-activated receptor gamma (PPAR-γ) in adipose tissue, which increases the transcription of genes involved in glucose and lipid metabolism. This leads to improved insulin sensitivity, reduced glucose production in the liver, and increased glucose uptake in the muscles. Additionally, thiazolidinediones have anti-inflammatory effects and can improve lipid profiles.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is likely to be a correct action of thiazolidinediones, as they do have a role in improving insulin sensitivity and reducing glucose levels.
**Option B:** This option is likely to be a correct action of thiazolidinediones, as they can improve lipid profiles by reducing triglycerides and increasing HDL cholesterol.
**Option C:** This option is likely to be a correct action of thiazolidinediones, as they can reduce blood pressure by improving insulin sensitivity and reducing vascular resistance.

**Clinical Pearl / High-Yield Fact**
Thiazolidinediones can cause fluid retention, particularly in patients with heart failure, and should be used with caution in these patients.

**Correct Answer:** A. (Note: The correct answer was not provided, so I assumed it was a placeholder. Please provide the correct options and answer for a complete explanation.)